Douglas A. Corley

Jul 19, 2024 | jamanetwork.com | Chyke A. Doubeni |Douglas A. Corley |Christopher Jensen |Theodore Levin

Key PointsQuestion  What is the colorectal cancer mortality benefit of screening with fecal immunochemical tests (FITs)? Findings  In this nested case control study of 10 711 individuals, completing a FIT to screen for colorectal cancer was associated with a reduction in risk of dying from colorectal cancer of approximately 33% overall, and there was a 42% lower risk for left colon and rectum cancers.